TP53 and poorly differentiated thyroid gland carcinoma: One model, characterized by a thyroid dox-inducible expression of BRAFV600E in a P53-/- genetic background (TetOn-BRAF-P53), developed high penetrant and poorly differentiated thyroid tumors that were similar to human poorly differentiated thyroid cancer (PDTC) and ATC.